PMC:7200337 / 102047-103276
Annnotations
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32505227-32253318-46575443 | 502-506 | 32253318 | denotes | 2020 |
32505227-32281317-46575444 | 1139-1143 | 32281317 | denotes | 2020 |
T98365 | 502-506 | 32253318 | denotes | 2020 |
T99026 | 1139-1143 | 32281317 | denotes | 2020 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T5 | 41-47 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
T6 | 216-220 | Body_part | denotes | body | http://purl.org/sig/ont/fma/fma256135 |
T7 | 507-512 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
T8 | 538-548 | Body_part | denotes | lymphocyte | http://purl.org/sig/ont/fma/fma62863 |
T9 | 695-703 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T10 | 891-896 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
T11 | 1163-1168 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T100 | 507-512 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
T101 | 891-896 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
T102 | 1163-1168 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T587 | 59-67 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T588 | 573-588 | Disease | denotes | lymphocytopenia | http://purl.obolibrary.org/obo/MONDO_0003783 |
T589 | 637-645 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T24 | 41-47 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | Plasma |
T25 | 110-112 | http://purl.obolibrary.org/obo/PR_000005794 | denotes | CP |
T26 | 164-166 | http://purl.obolibrary.org/obo/CLO_0009715 | denotes | yo |
T27 | 183-185 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T28 | 419-421 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
T29 | 425-427 | http://purl.obolibrary.org/obo/CLO_0009715 | denotes | yo |
T30 | 507-512 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
T31 | 602-606 | http://purl.obolibrary.org/obo/CLO_0008947 | denotes | SaO2 |
T32 | 602-606 | http://purl.obolibrary.org/obo/CLO_0050140 | denotes | SaO2 |
T33 | 752-754 | http://purl.obolibrary.org/obo/CLO_0009715 | denotes | yo |
T34 | 791-793 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T35 | 891-896 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
T36 | 957-959 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
T37 | 1002-1004 | http://purl.obolibrary.org/obo/PR_000005794 | denotes | CP |
T38 | 1083-1085 | http://purl.obolibrary.org/obo/CLO_0054055 | denotes | 71 |
T39 | 1086-1088 | http://purl.obolibrary.org/obo/CLO_0009715 | denotes | yo |
T40 | 1099-1101 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T41 | 1163-1168 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
T42 | 1181-1183 | http://purl.obolibrary.org/obo/CLO_0009715 | denotes | yo |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T51573 | 110-112 | Chemical | denotes | CP | http://purl.obolibrary.org/obo/CHEBI_3380|http://purl.obolibrary.org/obo/CHEBI_73461 |
T93279 | 1002-1004 | Chemical | denotes | CP | http://purl.obolibrary.org/obo/CHEBI_3380|http://purl.obolibrary.org/obo/CHEBI_73461 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T58 | 573-588 | Phenotype | denotes | lymphocytopenia | http://purl.obolibrary.org/obo/HP_0001888 |
T59 | 648-655 | Phenotype | denotes | viremia | http://purl.obolibrary.org/obo/HP_0020071 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 759-770 | http://purl.obolibrary.org/obo/GO_0009056 | denotes | degradation |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3362 | 1002-1004 | Gene | denotes | CP | Gene:1356 |
3363 | 110-112 | Gene | denotes | CP | Gene:1356 |
3364 | 77-84 | Species | denotes | Patient | Tax:9606 |
3365 | 148-156 | Species | denotes | patients | Tax:9606 |
3366 | 268-276 | Species | denotes | patients | Tax:9606 |
3367 | 409-417 | Species | denotes | patients | Tax:9606 |
3368 | 559-567 | Species | denotes | patients | Tax:9606 |
3369 | 614-622 | Species | denotes | patients | Tax:9606 |
3370 | 661-669 | Species | denotes | patients | Tax:9606 |
3371 | 716-724 | Species | denotes | patients | Tax:9606 |
3372 | 736-744 | Species | denotes | patients | Tax:9606 |
3373 | 920-927 | Species | denotes | patient | Tax:9606 |
3374 | 940-948 | Species | denotes | patients | Tax:9606 |
3375 | 1048-1056 | Species | denotes | patients | Tax:9606 |
3376 | 1066-1074 | Species | denotes | patients | Tax:9606 |
3377 | 378-381 | Chemical | denotes | nAb | |
3378 | 573-588 | Disease | denotes | lymphocytopenia | MESH:D008231 |
3379 | 637-655 | Disease | denotes | SARS-CoV-2 viremia | MESH:C000657245 |
3381 | 59-67 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T598 | 0-76 | Sentence | denotes | Table 4 Clinical Studies of Convalescent Plasma Therapy in COVID-19 Patients |
T599 | 77-138 | Sentence | denotes | Patient Characteristics Start of CP Therapy Results Reference |
T600 | 139-294 | Sentence | denotes | 5 severe patients (30–70 yo) between 10 and 22 days after hospital admission body temperature normalized within 3 days in 4 of 5 patients Shen et al., 2020 |
T601 | 295-315 | Sentence | denotes | clinical improvement |
T602 | 316-377 | Sentence | denotes | viral loads became negative within 12 days of the transfusion |
T603 | 378-398 | Sentence | denotes | nAb titers increased |
T604 | 399-506 | Sentence | denotes | 10 severe patients (34–78 yo) median 16.5 dpo disappearance of clinical symptoms after 3d Duan et al., 2020 |
T605 | 507-524 | Sentence | denotes | chest CT improved |
T606 | 525-589 | Sentence | denotes | elevation of lymphocyte counts in patients with lymphocytopenia. |
T607 | 590-622 | Sentence | denotes | increase in SaO2 in all patients |
T608 | 623-669 | Sentence | denotes | resolution of SARS-CoV-2 viremia in 7 patients |
T609 | 670-724 | Sentence | denotes | increase in neutralizing antibody titers in 5 patients |
T610 | 725-871 | Sentence | denotes | 4 critical patients (31–73 yo) at degradation of symptoms,between 11 and 19 days after hospital admission clinical improvement Zhang et al., 2020b |
T611 | 872-890 | Sentence | denotes | reduced viral load |
T612 | 891-908 | Sentence | denotes | chest CT improved |
T613 | 909-1021 | Sentence | denotes | 1 moderate patient, 2 critical patients 12 dpo, 27 dpo viral detection negative 4 days after CP Pei et al., 2020 |
T614 | 1022-1056 | Sentence | denotes | clinical improvement of 2 patients |
T615 | 1057-1143 | Sentence | denotes | 2 severe patients (67 and 71 yo) 7 dpo or 22 dpo clinical improvement Ahn et al., 2020 |
T616 | 1144-1162 | Sentence | denotes | reduced viral load |
T617 | 1163-1180 | Sentence | denotes | chest CT improved |
T618 | 1181-1229 | Sentence | denotes | yo, years old; dpo, days post onset of symptoms. |